Search

Substituted Indole Compounds With Inhibitory Activity for Treating Acute Renal Failure

USPTO granted patent US12606557B2 to the University of Pittsburgh-of the Commonwealth System of Higher Education on April 21, 2026. The patent covers substituted indole compounds and compositions for treating or preventing acute renal failure, as well as infectious diseases and cancer. The application (No. 17927406) was filed on May 27, 2021, with 17 claims and CPC classification C07D 471/04.